Mechanistically, high PDPN expression in stromal cells upregulates CAF activation markers, enhances RhoA-mediated cytoskeletal contractility, and promotes ECM protein synthesis, thereby fostering a niche that supports colon adenocarcinoma cell growth (Fig. 8). The gene discussed is PDPN; the disease is colon adenocarcinoma.